Insider Selling: DLH Holdings Corp. (DLHC) Director Sells 2,706 Shares of Stock

DLH Holdings Corp. (NASDAQ:DLHC) Director William H. Alderman sold 2,706 shares of the firm’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $5.76, for a total transaction of $15,586.56. Following the transaction, the director now directly owns 84,250 shares in the company, valued at $485,280. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

DLH Holdings Corp. (NASDAQ:DLHC) traded up $0.03 during mid-day trading on Monday, reaching $5.76. 11,268 shares of the company’s stock traded hands, compared to its average volume of 10,982. DLH Holdings Corp. has a 52-week low of $4.10 and a 52-week high of $6.83. The company has a market cap of $68.09, a price-to-earnings ratio of 20.46 and a beta of 0.20.

DLH (NASDAQ:DLHC) last released its earnings results on Tuesday, February 6th. The business services provider reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. DLH had a net margin of 0.09% and a return on equity of 10.06%. The firm had revenue of $30.22 million for the quarter, compared to analyst estimates of $29.00 million. analysts anticipate that DLH Holdings Corp. will post 0.56 earnings per share for the current fiscal year.

A number of hedge funds have recently added to or reduced their stakes in DLHC. Commonwealth Equity Services Inc bought a new position in DLH in the 3rd quarter valued at about $2,342,000. Dimensional Fund Advisors LP bought a new position in DLH in the 3rd quarter valued at about $121,000. Finally, Renaissance Technologies LLC increased its holdings in DLH by 8.9% in the 4th quarter. Renaissance Technologies LLC now owns 161,290 shares of the business services provider’s stock valued at $994,000 after buying an additional 13,200 shares during the period. 58.57% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities analysts recently commented on DLHC shares. Zacks Investment Research raised shares of DLH from a “hold” rating to a “buy” rating and set a $7.00 price target on the stock in a research report on Friday, December 8th. TheStreet lowered shares of DLH from a “b-” rating to a “c” rating in a research report on Thursday, February 8th. Finally, ValuEngine raised shares of DLH from a “hold” rating to a “buy” rating in a research report on Friday, March 2nd. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. DLH presently has a consensus rating of “Buy” and an average target price of $7.00.

ILLEGAL ACTIVITY NOTICE: This report was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at

About DLH

DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veteransÂ’ health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.

Insider Buying and Selling by Quarter for DLH (NASDAQ:DLHC)

Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with's FREE daily email newsletter.

Leave a Reply